Modera Wealth Management LLC Boosts Stock Holdings in Zoetis Inc. $ZTS

Modera Wealth Management LLC boosted its position in shares of Zoetis Inc. (NYSE:ZTS) by 5.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 32,470 shares of the company’s stock after buying an additional 1,579 shares during the quarter. Modera Wealth Management LLC’s holdings in Zoetis were worth $5,064,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of ZTS. Nova Wealth Management Inc. purchased a new position in Zoetis during the first quarter worth approximately $25,000. 1248 Management LLC acquired a new position in Zoetis during the first quarter worth $27,000. Saudi Central Bank purchased a new position in Zoetis during the first quarter valued at $29,000. Cornerstone Planning Group LLC increased its stake in shares of Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock worth $30,000 after purchasing an additional 88 shares in the last quarter. Finally, REAP Financial Group LLC increased its stake in shares of Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after purchasing an additional 131 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Argus reiterated a “buy” rating and set a $190.00 price target on shares of Zoetis in a research report on Tuesday, September 9th. Leerink Partners downgraded Zoetis from an “outperform” rating to a “market perform” rating and reduced their price objective for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Piper Sandler lifted their target price on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Finally, UBS Group reduced their target price on shares of Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research report on Wednesday. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $191.00.

Zoetis Trading Up 0.5%

Shares of ZTS stock opened at $120.20 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a twelve month low of $117.26 and a twelve month high of $181.85. The company’s 50-day moving average price is $144.21 and its 200-day moving average price is $152.60. The stock has a market cap of $53.27 billion, a price-to-earnings ratio of 20.69, a PEG ratio of 2.31 and a beta of 0.90.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.42 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. Zoetis’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a yield of 1.7%. Zoetis’s dividend payout ratio (DPR) is 33.67%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.